Browse > Article
http://dx.doi.org/10.5487/TR.2013.29.1.053

Milk Transfer and Toxicokinetics of Valproic Acid in Lactating Cynomolgus Monkeys  

Lee, Jong-Hwa (Korea Institute of Toxicology, KRICT)
Yu, Wook-Joon (Korea Institute of Toxicology, KRICT)
Jeong, Eun Ju (Korea Institute of Toxicology, KRICT)
Chung, Moon-Koo (Korea Institute of Toxicology, KRICT)
Publication Information
Toxicological Research / v.29, no.1, 2013 , pp. 53-60 More about this Journal
Abstract
Studies on milk transfer of drugs in non-human primates (NHPs) are among the crucial components in the assessment of peri- and postnatal toxicity because of the similarity between NHPs and humans. To evaluate the milk transfer of valproic acid (VPA) in NHPs, the toxicokinetics of VPA, an antiepileptic drug, were studied in pregnant cynomolgus monkeys. VPA was administered once daily to pregnant cynomolgus monkeys at doses of 0, 30, 90, and 270 mg/kg by oral gavage from Day 100 of gestation (GD 100) to Day 31 of lactation (LD 31). Concentrations of VPA and its metabolite, 4-ene-VPA, in the maternal plasma on GD 100, GD 140, and LD 30, and concentrations of VPA and 4-ene-VPA in the offspring plasma and milk on LDs 30 and 31, respectively, were quantified using liquid chromatography tandem mass spectrometry (LC/MS/MS). After administration of a single oral dose of VPA to pregnant monkeys on GD 100, the concentrations of VPA and 4-ene-VPA were generally quantifiable in the plasma of all treatment groups up to 24 hr after administration, which showed that VPA was absorbed and that the monkeys were systemically exposed to VPA and 4-ene-VPA. After administration of multiple doses of VPA to the monkeys, VPA was detected in the pup's plasma and in milk taken on LD 30 and LD 31, respectively, which showed that VPA was transferred via milk, and the pup was exposed to VPA. Further, the concentration of VPA in the milk increased with an increase in the dose. Extremely low concentrations of 4-ene VPA were detected in the milk and in the pup plasma. In conclusion, pregnant monkeys were exposed to VPA and 4-ene-VPA after oral administration of VPA at doses of 30, 90, and 270 mg/kg/day from GD 100 to LD 31. VPA was transferred via milk, and the VPA exposure to the pup increased with an increase in the dose of VPA. The metabolite, 4-ene VPA, was present in extremely low concentrations (< 0.5 ${\mu}g/ml$) in the milk and in the pup plasma. In this study, we established methods to confirm milk transfer in NHPs, such as mating and diagnosis of pregnancy by examining gestational sac with ultrasonography, collection of milk and pup plasma and determination of toxicokinetics, using cynomolgus monkeys.
Keywords
Non-human primate; Cynomolgus monkey; Milk transfer; Toxicokinetics; Valproic acid; 4-ene valproic acid; LC/MS/MS;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Jeong, E.J., Yu, W.J., Kim, C.Y. and Chung, M.K. (2010) Placenta transfer and toxicokinetics of valproic acid in pregnant cynomolgus monkeys. Toxicol. Res., 26, 275-283.   DOI   ScienceOn
2 Dickinson, R.G., Lawyer, C.H., Kaufman, S.N., Lynn, R.K., Gerber, N., Novy, M.J. and Cook, M.J. (1980a) Maternofetal pharmacokinetics and fetal distribution of valproic acid in the pregnant rhesus monkey. Pediatr. Pharmacol., 1, 71-83
3 Dickinson, R.G., Taylor, S.M., Kaufman, S.N., Rodgers, R.M., Lynn, R.K., Gerber, N. and Baughman, W.L. (1980b) Nonlinear elimination and choleretic effect of VPA in the monkey. J. Pharmacol. Exp. Ther., 213, 38-48.
4 Ludden, T.M. (1991) Nonlinear pharmacokinetics: clinical implicantions. Clin. Pharmacokinet., 20, 429-446.   DOI   ScienceOn
5 Rettenmeier, A.W., Gordon, W.P., Prickett, K.S., Levy, R.H. and Baillie, T.A. (1986a) Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Drug Metab. Dispos., 14, 454-464.
6 Ornoy, A. (2006) Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod. Toxicol., 22, 214-226.   DOI   ScienceOn
7 Rosenberg, G. (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell. Mol. Life Sci., 64, 2090-2103.   DOI
8 Wide, K., Winbladh, B. and Källén, B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr., 93, 174-176.   DOI
9 Alsdorf, R. and Wyszynski, D.F. (2005) Teratogenicity of sodium valproate. Expert Opin. Drug Saf., 4, 345-353.   DOI   ScienceOn
10 Binkerd, P.E., Rowland, J.M., Nau, H. and Hendrickx, A.G. (1988) Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam. Appl. Toxicol., 11, 485-493.   DOI   ScienceOn
11 Rettenmeier, A.W., Gordon, W.P., Prickett, K.S., Levy, R.H., Lockard, J.S., Thummel, K.E. and Baillie, T.A. (1986b) Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid. Drug Metab. Dispos., 14, 443-453.
12 Bennett, P.N. (1988) Drugs and human lactation. Elsevier, New York, pp. 341-342.
13 von Unruh, G.E., Froescher, W., Hoffmann, F. and Niesen, M. (1984) Valproic acid in breast milk: how much is really there? Ther. Drug Monit., 6, 272-276   DOI
14 Albani, F., Riva, R., Contin, M., Baruzzi, A., Altomare, M., Merlini, G.P. and Perucca, E. (1984) Differential transplantal binding of valproic acid: influence of free fatty acids. Br. J. Clin. Pharmacol., 17, 759-762.   DOI   ScienceOn
15 Tsuru, N., Maeda, T. and Tsuruoka, M. (1988) Three cases of delivery under sodium valproate-placental transfer, milk transfer and probable teratogenecity of sodium valproate. Jpn. J. Psychiatry Neurol., 42, 89-96.
16 Hendrickx, A.G., Nau, H., Binkerd, P., Rowland, J.M., Rowland, J.R., Cukierski, M.J. and Cukierski, M.A. (1988) Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison. Teratology, 38, 329-345.   DOI   ScienceOn
17 Hawkes, W.C., Willhite, C.C., Omaye, S.T., Cox, D.N., Choy, W.N. and Tarantal, A.F. (1994) Selenium kinetics, placental transfer, and neonatal exposure in cynomolgus macaques (Macaca fascicularis). Teratology, 50, 148-159.   DOI   ScienceOn
18 Takahashi, M., Shibutani, M., Nakahigashi, J., Sakaguchi, N., Inoue, K., Morikawa, T., Yoshida, M. and Nishikawa, A. (2009) Limited lactational transfer of acrylamide to rat offspring on maternal oral administration during the gestation and lactation periods. Arch. Toxicol., 83, 785-793.   DOI
19 Doerge, D.R., Vanlandingham, M., Twaddle, N.C. and Delclos, K.B. (2010) Lactational transfer of bisphenol A in Sprague- Dawley rats. Toxicol. Lett., 199, 372-376.   DOI   ScienceOn
20 Nau, H. (1986) Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect., 70, 113-129.   DOI   ScienceOn
21 Brown, N.A. and Fabro, S. (1983) The value of animal teratogenicity testing for predicting human risk. Chin. Obstet. Gynecol., 26, 467-477.
22 Mast, T.J., Hendrickx, A.G. and Nau, H. (1985) Teratology and pharmacokinetics of valproic acid in the rhesus monkey. Teratology, 31, 25A.
23 Neubert, D. and Chahoud, I. (1985) Significance of species and strain differences in pre- and perinatal toxicology. Arch. Histochem. Suppl., 31, 23-35.
24 Schardein, J.L., Schwetz, B.A. and Kenel, M.F. (1985) Species sensitivities and prediction of teratogenic potential. Environ. Health Perspect., 61, 55-67
25 Ornoy, A. (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod.Toxicol., 28, 1-10.   DOI   ScienceOn